@Dangerous_beans The drug wouldn’t exist at all if Gilead hadn’t had an incentive to spend money on R&D, clinical trials, and the approvals process, and make at least some profit out the back end. And that would leave all of us worse off.
So where would you propose that money come from, or what alternative incentive structure are you proposing to ensure drug discovery continues to happen?